Unicycive Therapeutics appoints Meredith Manning to board, names her nominating committee chair

Bitget2026/10/01 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Unicycive Therapeutics appointed Meredith Manning to its board.
Manning joined the audit, compensation, nominating and corporate governance committees. She will chair the nominating and corporate governance committee.
She was chief commercial officer at Soleno Therapeutics from 2024 until its 2026 acquisition by Neurocrine Biosciences.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Unicycive Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010705PRIMZONEFULLFEED9837556) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Unicycive Therapeutics appoints Meredith Manning to board, names her nominating committee chair

You may also like

Crypto prices